8-KThe WireRoutine
Shareholder Vote · Company Update
Filed Aug 1, 2023 · 2y ago · Accession 0001213900-23-061514
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Estrella Immunopharma, Inc.
- Ticker
- ESLAW
- CIK
- 1844417
- Form type
- 8-K
- Filing date
- Aug 1, 2023
- Report date
- Jul 31, 2023
- Document
- ea182664-8k425_tradeup.htm
- Size
- 304 KB